Technical Analysis for AEMD - Aethlon Medical, Inc.

Grade Last Price % Change Price Change
grade F 1.01 -1.94% -0.02
AEMD closed down 1.94 percent on Tuesday, March 19, 2019, on 67 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical AEMD trend table...

Date Alert Name Type % Chg
Mar 19 Shooting Star Candlestick Bearish 0.00%
Mar 19 20 DMA Support Bullish 0.00%
Mar 19 Bollinger Band Squeeze Range Contraction 0.00%
Mar 19 Doji - Bearish? Reversal 0.00%
Mar 19 BB Squeeze + Upper Band Touch Range Contraction 0.00%
Mar 19 Upper Bollinger Band Touch Strength 0.00%
Mar 18 Death Cross Bearish -1.94%
Mar 18 1,2,3 Retracement Bearish Bearish Swing Setup -1.94%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.94%
Mar 18 Crossed Above 20 DMA Bullish -1.94%

Older signals for AEMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aethlon Medical, Inc., a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The company's Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. It is also developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. The company was founded in 1991 and is based in San Diego, California.
Medicine Health Cancer Biology Infectious Diseases Treatment Of Cancer Neurological Disorders Healthcare Associated Infections Infectious Causes Of Cancer Antiviral Drug Hepatitis Virus Sepsis Exosome Vesicles
Is AEMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.74
52 Week Low 0.82
Average Volume 108,058
200-Day Moving Average 1.2039
50-Day Moving Average 1.193
20-Day Moving Average 1.0091
10-Day Moving Average 1.0052
Average True Range 0.0639
ADX 36.43
+DI 11.0651
-DI 19.8255
Chandelier Exit (Long, 3 ATRs ) 0.9483
Chandelier Exit (Short, 3 ATRs ) 1.1517
Upper Bollinger Band 1.0456
Lower Bollinger Band 0.9726
Percent B (%b) 0.51
BandWidth 7.234169
MACD Line -0.0461
MACD Signal Line -0.0601
MACD Histogram 0.014
Fundamentals Value
Market Cap 8.99 Million
Num Shares 8.9 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -1.16
Price-to-Sales 22.89
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.08
Resistance 3 (R3) 1.09 1.07 1.07
Resistance 2 (R2) 1.07 1.05 1.07 1.07
Resistance 1 (R1) 1.04 1.04 1.03 1.03 1.06
Pivot Point 1.02 1.02 1.02 1.02 1.02
Support 1 (S1) 0.99 1.00 0.99 0.99 0.96
Support 2 (S2) 0.97 0.99 0.97 0.95
Support 3 (S3) 0.94 0.97 0.95
Support 4 (S4) 0.94